Orig3N, LabCorp Collaborate on iPSC
News May 20, 2015
Orig3N have announced that Laboratory Corporation of America has invested in the firm and will provide storage for Orig3N's induced pluripotent stem cell repository.
The Boston-based biotech firm did not disclose the amount of LabCorp's investment. LabCorp will provide storage for the iPSC repository called LifeCapsule in its biorepository facilities and will perform genetic testing on the stored cells. The partnership will increase LifeCapsule's utility and create a well-characterized library of specimens, Orig3N said.
The company is developing a disease-modeling platform targeting rare genetically inherited diseases. In February, it raised $3.1 million in a private financing round.
Scientists with Novel Approaches to Fighting Cancer Awarded $3MNews
The Damon Runyon Cancer Research Foundation announced that ten scientists with novel approaches to fighting cancer have been named 2018 recipients of the Damon Runyon-Rachleff Innovation Award.READ MORE
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE